Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (511-520 of 1,137) with videos related to

Pageof 114
Sort By:
Mycoses|May 10, 2006
Evaluation of antifungals in the surgical intensive care unit: a multi-institutional studyKevin W Garey, Melinda M Neuhauser, David T Bearden, et al.
Critical Pathways in Cardiology|March 15, 2008
Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudyHoward C Herrmann, Sabina A Murphy, Peter M Dibattiste, et al.
Chronobiology International|November 8, 2012
Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarctionOwen Mogabgab, Robert P Giugliano, Marc S Sabatine, et al.
Diabetes, Obesity & Metabolism|February 15, 2017
Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trialBrian A Bergmark, Christopher P Cannon, William B White, et al.
Journal of the American College of Cardiology|March 18, 1999
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial InfarctionK A Ault, C P Cannon, J Mitchell, et al.
The American Journal of Cardiology|November 28, 2018
Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial)Muthiah Vaduganathan, William B White, David M Charytan, et al.
Investigative Ophthalmology & Visual Science|April 26, 2003
Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit modelJoan P Cannon, Richard Fiscella, Sutthiporn Pattharachayakul, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|December 18, 2007
Crystallization and X-ray diffraction analysis of a novel immune-type receptor from Ictalurus punctatus and phasing by selenium anomalous dispersion methodsDavid A Ostrov, José A Hernández Prada, Robert N Haire, et al.
Critical Pathways in Cardiology|March 15, 2008
Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guidelineGregg C Fonarow, William T Abraham, Mihai Gheorghiade, et al.
Journal of Thrombosis and Thrombolysis|April 20, 2006
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials)Shaheeda Ahmed, Elliott M Antman, Sabina A Murphy, et al.
Pageof 114

Showing results (511-520 of 1,137) with videos related to

Sort By:
Pageof 114
Mycoses|May 10, 2006
Evaluation of antifungals in the surgical intensive care unit: a multi-institutional studyKevin W Garey, Melinda M Neuhauser, David T Bearden, et al.
Critical Pathways in Cardiology|March 15, 2008
Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudyHoward C Herrmann, Sabina A Murphy, Peter M Dibattiste, et al.
Chronobiology International|November 8, 2012
Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarctionOwen Mogabgab, Robert P Giugliano, Marc S Sabatine, et al.
Diabetes, Obesity & Metabolism|February 15, 2017
Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trialBrian A Bergmark, Christopher P Cannon, William B White, et al.
Journal of the American College of Cardiology|March 18, 1999
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial InfarctionK A Ault, C P Cannon, J Mitchell, et al.
The American Journal of Cardiology|November 28, 2018
Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial)Muthiah Vaduganathan, William B White, David M Charytan, et al.
Investigative Ophthalmology & Visual Science|April 26, 2003
Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit modelJoan P Cannon, Richard Fiscella, Sutthiporn Pattharachayakul, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|December 18, 2007
Crystallization and X-ray diffraction analysis of a novel immune-type receptor from Ictalurus punctatus and phasing by selenium anomalous dispersion methodsDavid A Ostrov, José A Hernández Prada, Robert N Haire, et al.
Critical Pathways in Cardiology|March 15, 2008
Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guidelineGregg C Fonarow, William T Abraham, Mihai Gheorghiade, et al.
Journal of Thrombosis and Thrombolysis|April 20, 2006
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials)Shaheeda Ahmed, Elliott M Antman, Sabina A Murphy, et al.
Pageof 114